Edesa Biotech CEO to receive 90% of salary as RSUs, up from 50%

Edesa Biotech, Inc.

CEO Pardeep Nijhawan will receive 90% of monthly base salary as fully vested RSUs, effective May 13, 2026.
Previously, 50% of base salary was issued as RSUs; remaining 10% paid in cash for withholding and tax requirements.
RSUs granted each month at month-end fair market value under the 2019 Equity Incentive Compensation Plan.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.